基于比价分析法探讨抗肿瘤药物价格合理性  

Rationality of Prices of Antineoplastic Drugs Based on Price Comparison Analysis

作　　者：王江流[1] 刘平羽[1] 李歆[2] 韩峰 WANG Jingliu;LIU Pingyu;LI Xin;HAN Feng(Department of Pharmacy,Second Affiliated Hospital of Nanjing Medical University,Nanjing Jiangsu 2100001;School of Pharmacy,Nanjing Medical University,Nanjing Jiangsu 210000,China)

机构地区：[1]南京医科大学第二附属医院,江苏南京210011 [2]南京医科大学药学院,江苏南京211166

出　　处：《中国药物警戒》2021年第12期1162-1165,共4页Chinese Journal of Pharmacovigilance

基　　金：国家自然科学基金资助项目(72074123,716731471);江苏省政策引导类计划(软科学研究)(BR2020043)。

摘　　要：目的对比分析现行抗肿瘤药品价格,对其存在的不合理状况进行实证分析。方法提取2020年1月江苏省公布的262个集中采购及36个国家谈判抗肿瘤药物,利用比价分析法,对原研药及仿制药、各类抗肿瘤药物、一线抗肿瘤药物及靶向抗肿瘤药物价格进行对比分析。结果原研与仿制药品价格极差为32.28,价格差距较大;各类抗肿瘤药物的平均极差为194.70,均值为36.44,标准差为58.01;抗肿瘤治疗指南推荐的一线用药价格差距较大,紫杉醇极差为5.33,同样规格的国产药品极差为33.30~144.89元之间。结论目前我国各类抗肿瘤药物的价格差距较大,品种规格数量较多,仍需采取系列措施完善抗肿瘤药物价格的形成机制,建立抗肿瘤药物价格的平衡点,平衡医药产业发展与药物可及性之间的矛盾。Objective To compare current prices of antineoplastic drugs and conduct an empirical analysis of irrationality.Methods Comparative analysis of prices was used to compare the prices of original drugs,generic drugs,antineoplastic drugs,first-line antineoplastic drugs and targeting agents.Results The price range between original and generic drugs was 32.28,which was significant difference.The average range,average value,and standard deviation of various antineoplastic drugs prices were 194.7,36.44,and 58.01,respectively.The prices of first-line drugs recommended by the anti-tumor treatment guidelines varied widely.For example,the range of paclitaxel was 5.33,and the range of domestic drugs with the same specifications was between 33.3 and 144.89.Conclusion There is a large price range and a large variety of antineoplastic drugs with different specifications in China.A series of measures needs to be taken to improve the mechanism of pricing,strike a balance between prices of antineoplastic drugs,and solve the contradiction between the development of the pharmaceutical industry and drug accessibility.

关 键 词：比价分析 抗肿瘤药 药品价格 合理性 

分 类 号：R994.11[医药卫生—毒理学]